180 related articles for article (PubMed ID: 11207634)
1. Determinants of changes in plasma homocysteine in hyperthyroidism and hypothyroidism.
Diekman MJ; van der Put NM; Blom HJ; Tijssen JG; Wiersinga WM
Clin Endocrinol (Oxf); 2001 Feb; 54(2):197-204. PubMed ID: 11207634
[TBL] [Abstract][Full Text] [Related]
2. Homocysteine, folate, and cobalamin levels in hyperthyroid women before and after treatment.
Orzechowska-Pawilojc A; Siekierska-Hellmann M; Syrenicz A; Sworczak K
Endokrynol Pol; 2009; 60(6):443-8. PubMed ID: 20041361
[TBL] [Abstract][Full Text] [Related]
3. Plasma total homocysteine levels in hyperthyroid and hypothyroid patients.
Nedrebø BG; Ericsson UB; Nygård O; Refsum H; Ueland PM; Aakvaag A; Aanderud S; Lien EA
Metabolism; 1998 Jan; 47(1):89-93. PubMed ID: 9440483
[TBL] [Abstract][Full Text] [Related]
4. Homocysteine, folate and cobalamin levels in hypothyroid women before and after treatment.
Orzechowska-Pawilojc A; Sworczak K; Lewczuk A; Babinska A
Endocr J; 2007 Jun; 54(3):471-6. PubMed ID: 17464093
[TBL] [Abstract][Full Text] [Related]
5. Plasma homocysteine concentrations in adolescents with subclinical hypothyroidism.
Atabek ME; Pirgon O; Erkul I
J Pediatr Endocrinol Metab; 2003 Dec; 16(9):1245-8. PubMed ID: 14714746
[TBL] [Abstract][Full Text] [Related]
6. Changes in plasma homocysteine levels of rats with experimentally induced hypothyroidism and hyperthyroidism.
Ozkan Y; Dönder E; Güney H; Baydaş G
Neuro Endocrinol Lett; 2005 Oct; 26(5):536-40. PubMed ID: 16264404
[TBL] [Abstract][Full Text] [Related]
7. Changes in plasma low-density lipoprotein (LDL)- and high-density lipoprotein cholesterol in hypo- and hyperthyroid patients are related to changes in free thyroxine, not to polymorphisms in LDL receptor or cholesterol ester transfer protein genes.
Diekman MJ; Anghelescu N; Endert E; Bakker O; Wiersinga WM
J Clin Endocrinol Metab; 2000 May; 85(5):1857-62. PubMed ID: 10843165
[TBL] [Abstract][Full Text] [Related]
8. Effect of MTHFR 677C>T on plasma total homocysteine levels in renal graft recipients.
Födinger M; Wölfl G; Fischer G; Rasoul-Rockenschaub S; Schmid R; Hörl WH; Sunder-Plassmann G
Kidney Int; 1999 Mar; 55(3):1072-80. PubMed ID: 10027946
[TBL] [Abstract][Full Text] [Related]
9. Plasma folate, vitamin B(12), and total homocysteine and homozygosity for the C677T mutation of the 5,10-methylene tetrahydrofolate reductase gene in patients with Alzheimer's dementia. A case-control study.
Postiglione A; Milan G; Ruocco A; Gallotta G; Guiotto G; Di Minno G
Gerontology; 2001; 47(6):324-9. PubMed ID: 11721146
[TBL] [Abstract][Full Text] [Related]
10. Hyperhomocysteinemia in children with renal transplants.
Aldámiz-Echevarría L; Sanjurjo P; Vallo A; Aquino L; Pérez-Nanclares G; Gimeno P; Rueda M; Ruiz I; Urreizti R; Rodríguez-Soriano J
Pediatr Nephrol; 2002 Sep; 17(9):718-23. PubMed ID: 12215824
[TBL] [Abstract][Full Text] [Related]
11. Impact of renal function or folate status on altered plasma homocysteine levels in hypothyroidism.
Ozmen B; Ozmen D; Parildar Z; Mutaf I; Turgan N; Bayindir O
Endocr J; 2006 Feb; 53(1):119-24. PubMed ID: 16543681
[TBL] [Abstract][Full Text] [Related]
12. Plasma homocysteine levels in hyperthyroid patients.
Demirbas B; Ozkaya M; Cakal E; Culha C; Gulcelik N; Koc G; Serter R; Aral Y
Endocr J; 2004 Feb; 51(1):121-5. PubMed ID: 15004418
[TBL] [Abstract][Full Text] [Related]
13. Methylene tetrahydrofolate reductase genotype and the risk and extent of coronary artery disease in a population with low plasma folate.
Tokgözoğlu SL; Alikaşifoğlu M; Unsal ; Atalar E; Aytemir K; Ozer N; Ovünç K; Usal O; Kes S; Tunçbilek E
Heart; 1999 May; 81(5):518-22. PubMed ID: 10212171
[TBL] [Abstract][Full Text] [Related]
14. Folate status is the major determinant of fasting total plasma homocysteine levels in maintenance dialysis patients.
Bostom AG; Shemin D; Lapane KL; Nadeau MR; Sutherland P; Chan J; Rozen R; Yoburn D; Jacques PF; Selhub J; Rosenberg IH
Atherosclerosis; 1996 Jun; 123(1-2):193-202. PubMed ID: 8782850
[TBL] [Abstract][Full Text] [Related]
15. Impact of thyroid dysfunction on serum cystatin C.
Fricker M; Wiesli P; Brändle M; Schwegler B; Schmid C
Kidney Int; 2003 May; 63(5):1944-7. PubMed ID: 12675875
[TBL] [Abstract][Full Text] [Related]
16. Factors explaining the difference of total homocysteine between men and women in the European Investigation Into Cancer and Nutrition Potsdam study.
Dierkes J; Jeckel A; Ambrosch A; Westphal S; Luley C; Boeing H
Metabolism; 2001 Jun; 50(6):640-5. PubMed ID: 11398138
[TBL] [Abstract][Full Text] [Related]
17. Homocysteine and its determinants in nondialyzed chronic kidney disease patients.
Nerbass FB; Draibe SA; Feiten SF; Chiarello PG; Vannucchi H; Cuppari L
J Am Diet Assoc; 2006 Feb; 106(2):267-70. PubMed ID: 16442876
[TBL] [Abstract][Full Text] [Related]
18. The C677T mutation in methylenetetrahydrofolate reductase gene, plasma homocysteine concentration and the risk of coronary artery disease.
Kadziela J; Janas J; Dzielińska Z; Szperl M; Gaździk D; Chotkowska E; Piotrowski W; Ruzyłło W
Kardiol Pol; 2003 Jul; 59(7):17-26; discussion 26. PubMed ID: 14560345
[TBL] [Abstract][Full Text] [Related]
19. Homocysteine and folate status in methotrexate-treated patients with rheumatoid arthritis.
van Ede AE; Laan RF; Blom HJ; Boers GH; Haagsma CJ; Thomas CM; De Boo TM; van de Putte LB
Rheumatology (Oxford); 2002 Jun; 41(6):658-65. PubMed ID: 12048292
[TBL] [Abstract][Full Text] [Related]
20. Folate, Cobalamin, Cysteine, Homocysteine, and Arsenic Metabolism among Children in Bangladesh.
Hall MN; Liu X; Slavkovich V; Ilievski V; Pilsner JR; Alam S; Factor-Litvak P; Graziano JH; Gamble MV
Environ Health Perspect; 2009 May; 117(5):825-31. PubMed ID: 19479028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
